BIOTOSCANA INVESTMENTS S.A. announced to its shareholders and the market in general that Mr. Claudio Coracini was appointed as the new Chief Executive Officer (interim) of Grupo Biotoscana. Mr. Federico Wintour is leaving the company. Change will be effective immediately. Claudio has over forty years of experience in the pharmaceutical market, and, most importantly, he knows GBT and has been part of the team for the last 5 years.